Notice of Effectiveness (effect)
13 Diciembre 2022 - 5:03AM
Edgar (US Regulatory)
UNITED STATES
|
---|
SECURITIES AND EXCHANGE COMMISSION
|
---|
Washington, D.C. 20549
|
---|
NOTICE OF EFFECTIVENESS |
---|
|
Effective Date: | December 12,
2022 |
---|
Form: | S-4 |
---|
CIK: | 0001100397 |
---|
Company Name: | Advaxis, Inc. |
---|
File Number: | 333-268586 |
---|
Ayala Pharmaceuticals (CE) (USOTC:ADXS)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Ayala Pharmaceuticals (CE) (USOTC:ADXS)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024
Real-Time news about Ayala Pharmaceuticals Inc (CE) (OTCMarkets): 0 recent articles
Más de Advaxis, Inc. Artículos de Noticias